Recce eyes US Defence grants with early data for R327 on burn wounds
Recce Pharma (ASX:RCE) has notched modest gains in the Tuesday arvo session after reporting its R327 anti-infective gel...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
STU | Ann: Removal from Official List | 30/05/11 | 0 | 986 | |||
|
|||||||
STU +SXY | Ann: Senex completes compulsory acquisition of St | 19/05/11 | 1 | 1.4K | |||
|
|||||||
STU | Ann: Final Director's Interest Notice | 09/05/11 | 0 | 786 | |||
|
|||||||
STU | Ann: Director Retirement | 09/05/11 | 0 | 738 | |||
|
|||||||
STU | Ann: March 2011 Quarterly Report | 29/04/11 | 0 | 1.0K | |||
|
|||||||
STU | Ann: Suspension from Official Quotation at close | 19/04/11 | 0 | 647 | |||
|
|||||||
STU +SXY | Ann: Senex lodges compulsory acquisition notice | 17:11 | 0 | 742 | |||
|
|||||||
STU +SXY | Ann: Change in substantial holding from SXY | 12/04/11 | 0 | 626 | |||
|
See All Discussions